News

The first transgenic cow has been bred to produce human insulin in her milk in a proof-of-concept achievement that could be scaled up after additional testing and FDA approval.

Just days after a single treatment of a new cell therapy, three glioblastoma patients experienced dramatic reductions in their tumors.

A promising novel drug candidate, designed at the atomic level, could help doctors halt the rise of lethal new drug-resistant SARS-CoV-2 variants.

A certain variant of a key anti-inflammatory gene protects men under age 75 from severe illness and death when hospitalized from COVID-19.

A new study identified a link between poor sleep and migraine attacks that suggests improving sleep health may diminish migraine attacks in people with migraine.

Trabectedin, a promising drug derived from the sea squirt Ecteinascidia turbinata, has shown potential in combating cancers resistant to conventional treatments. However, its precise mechanism of action has remained elusive—until now.

Progesterone has been shown to help prevent preterm birth in women with a short cervix.

A candidate drug for Alzheimer’s disease, donanemab, will be further scrutinized by a US Food and Drug Administration (FDA) expert panel, drugmaker announces.

A team of University of Michigan researchers has successfully modified a naturally occurring chemical compound in the lab, resulting in advanced lead compounds with anti-HIV activity.

The first atom-level model of a DNA-packed viral capsid reveals genome structure and possible new drug targets, University of Illinois researchers report.